Related Experiment Video
Updated: Dec 25, 2025

Using Learning Outcome Measures to assess Doctoral Nursing Education
Published on: June 21, 2010
A Pilot Study Regarding Pharmacy Law Education Across Doctor of Pharmacy Programs
Ettie Rosenberg1, Erin L Albert2, Geoffrey A Mospan3
1West Coast University School of Pharmacy, Los Angeles, California.
Abstract:
Objective. To describe the features of pharmacy law education in Doctor of Pharmacy (PharmD) programs in the United States. Methods. A review of the literature found no prior published data describing the delivery of pharmacy law education across PharmD programs in the United States. Members of the Pharmacy Law Educators Subcommittee of the American Society for Pharmacy Law (ASPL) developed questions for a survey. The survey was administered electronically to all 139 American Association of Colleges of Pharmacy (AACP) member institutions in the summer of 2016. A link to complete the 32-item online survey was distributed via email to the pharmacy law educator or associate dean at each AACP member institution. Results. Of the 139 PharmD programs surveyed, 49 completed the survey instrument, yielding a response rate of 35.2%. Variations between programs were found in the professional background of pharmacy law instructors and assessment strategies for pharmacy law courses, as well as in the structure and placement of the main pharmacy law course within the various curricula. Conclusion. This pilot study represents the first and only known attempt to examine delivery of pharmacy law education across colleges of pharmacy. The variations between programs found in this study highlight the need for further investigation into this area of pharmacy education.
More Related Videos
Related Concept Videos
Bioavailability Study Design: Single Versus Multiple Dose Studies
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmacokinetics in Pediatric Patients: Drug Distribution
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials
There are four phases in a clinical trial. A phase one...

